United States: New HIPAA Rules Regarding Genetic Information Affect Employers, Group Health Plans, Health Insurers And Healthcare Providers

Overview of HIPAA Amendments (Duane Morris Alert, January 29, 2013)

Business associate definition under 2013 HIPAA Amendments (Duane Morris Alert, January 23, 2013)

Breach notification under 2013 HIPAA Amendments (Duane Morris Alert, January 25, 2013)

Minimum necessary standard under HIPAA amendments (Duane Morris Alert, February 11, 2013)

Group health plans under HIPAA amendments (Duane Morris Alert, February 22, 2013)

Genetic Information Under HIPAA

While the final rule supplementing and modifying the Health Insurance Portability and Accountability Act (HIPAA) Privacy, Security, Breach Reporting and Enforcement Rules—78 Fed. Reg. 5565 (Jan. 25, 2013)—has been extensively reported on and analyzed, the section of the rule implementing the Genetic Information Nondiscrimination Act of 2008 (GINA) has not received nearly as much attention. This most likely results from the fact that while the non-GINA portions of the final rule will have an industry-wide impact, the section addressing GINA primarily affects health insurers. Because HIPAA includes employer-sponsored group health plans under the definition of insurers, employers that sponsor plans are also affected by the GINA amendments to the HIPAA Privacy Rule ("the GINA amendments"). In addition, the GINA amendments will have applicability beyond the insurance industry because they draw distinctions between permissible and impermissible uses of "genetic information" in connection with the diagnosis of a medical condition. The diagnosis of a medical condition is made by a healthcare provider and, as a result, the healthcare provider will have to determine whether genetic information was used in connection with a given diagnosis and, if so, how that information is required to be handled.

The Genetic Information Nondiscrimination Act

GINA has two primary components: an employment component that restricts employers from requesting, requiring or using genetic information; and a health insurance component that prohibits insurers from using such information in setting premiums and determining eligibility. The statute required the U.S. Department of Health and Human Services (HHS) to implement the health insurance component by promulgating regulations amending the HIPAA Privacy Rule to include genetic information within the definition of "health information." The GINA amendments were issued to fulfill this statutory mandate.

The GINA Amendments

The GINA amendments, which will become effective on March 26, 2013, implement the statutory prohibition on the use or disclosure of genetic information by a health plan for underwriting purposes. HHS chose to do this largely through the definitions of the key terms in the regulations. With one notable exception, the definition of "health plan" is largely unremarkable. Similarly, the definition of "underwriting purposes" is fairly straightforward. The definition of genetic information is somewhat more complicated.

1. "Health Plan"

Prior to the promulgation of the GINA amendments, the HIPAA Privacy Rule had defined health plan expansively to encompass virtually any plan that provides or pays for the cost of medical care, such as health maintenance organizations (HMOs); indemnity health insurers; and employer-sponsored group health plans. GINA required HHS to modify the HIPAA Privacy Rule to prohibit four specific types of entities—group health plans, health insurance issuers, health maintenance organizations and issuers of Medicare supplemental policies—from using genetic information for underwriting purposes. In its Notice of Proposed Rulemaking, HHS proposed to make the expansive pre-GINA HIPAA definition of health plan applicable to GINA.

The expansive definition of health plan in the proposed rule included long-term care insurance. Some rulemaking comments objected to this inclusion, contending (1) that HHS lacked the authority to include, within the definition of health plan applicable to GINA, plans not specifically mentioned in GINA; and (2) that applying the GINA prohibition to long-term care insurers would jeopardize their ability adequately to underwrite such policies, thus jeopardizing the viability of the long-term care insurance market.

Stating that it had the authority to include plans not mentioned in GINA, HHS opted to retain the existing broad definition of health plan, with the exception of long-term care policies. While HHS appeared to be unconvinced that the inclusion of long-term care policies within the definition of health plans would have an adverse impact on the market for such policies, it nevertheless exempted them because the agency did not have sufficient information on the issue.

In addition, the GINA amendments require health plans that perform underwriting to include in their Notice of Privacy Practices (NPP) a statement that they are prohibited from using or disclosing genetic information for underwriting purposes, as defined below.

2. "Underwriting Purposes"

The GINA amendments define "underwriting purposes" to mean anything related to the creation, renewal or replacement of a contract for health insurance benefits, such as determinations of eligibility; determinations of the cost of premiums; and determinations of the applicability of an exclusion for a preexisting condition.

The definition of "underwriting services" has had a direct impact on group health plans. Prior to the GINA amendments, group health plans were permitted to disclose summary health information to the plan sponsor for the purpose of obtaining quotes on premiums from health plans (e.g., HMOs) or for modifying, amending or terminating the group health plan. Because these activities fit squarely within the definition of underwriting purposes, the prohibition on the disclosure of genetic information is now applicable to group health plans.

However, in instances when an existing policy holder is seeking a benefit under a health plan, the determination of the medical appropriateness of the treatment by the plan is not an underwriting purpose, and genetic information may be used for this purpose.

3. "Genetic Information"

Genetic information is the third key term used in the GINA prohibition, and its most important, because its definition is the core element of the GINA amendments. The distinctions HHS has made regarding the types of information that are protected under the regulations, and the types of information that are not protected, are contained within the definition of genetic information. This definition is somewhat complex, however, because it relies on numerous terms that require their own definitions.

The GINA amendments define genetic information to mean (a) information about the "genetic tests" of an individual, the genetic tests of an individual's "family members" and information about the "manifestation" of a disease or disorder of an individual's family members (i.e., family medical history). Genetic information also includes information about any request for, or receipt of, "genetic services," as well as information about any participation in clinical research that includes genetic services.

An individual's family member is defined broadly to encompass dependents, up to "fourth-degree" blood relatives (i.e., great-grandparents) of either the individual or a dependent, and relatives by "affinity" (by marriage or adoption).

An individual's "dependent" is any person who is, or who may become, eligible for coverage under a group health plan because of that person's relationship to the individual.

The term "genetic services" means (1) a genetic test, (2) genetic counseling or (3) genetic education. A genetic test is an analysis of human DNA, RNA, chromosomes, proteins or metabolites that detects genotypes, mutations or chromosomal changes. The definition of genetic test, however, does not include an analysis of proteins or metabolites that is directly related to a "manifested" disease, disorder, or pathological condition.

A disease, disorder or pathological condition is manifested if it has been, or could reasonably be, diagnosed by a healthcare professional, with expertise in the appropriate field of medicine, on the basis of a physical examination. A disease, disorder or pathological condition is not "manifested," however, if the diagnosis is based principally on genetic information.

HHS used this distinction because genetic variants associated with diseases do not all have the same degree of predictive power for later development of the disease. In some instances, an individual may have a genetic variant associated with a particular disease and never develop the disease. In other instances, the presence of a genetic variant indicates that the individual will develop the disease—eventually. There may be no clinical symptoms of the disease for many decades after a positive test for the presence of the genetic variant. In this situation, the disease is not manifested by the presence of the genetic variant by itself, without any physical symptoms, even if it is certain that the individual will eventually develop the disease. HHS used the example of Huntington's disease to illustrate this point.

In this example, an individual's family member has been diagnosed with Huntington's disease, and a genetic test of the individual indicates the presence of the Huntington's disease gene variant. The individual subsequently consults a neurologist with expertise in Huntington's disease because the individual has begun to experience symptoms associated with the disease. In these circumstances, Huntington's disease is not manifested if a physical examination does not support a diagnosis of Huntington's disease. However, if a physician with expertise in Huntington's disease makes a diagnosis of the disease on the basis of a patient's symptoms, and uses genetic tests to confirm the diagnosis, the disease will be considered manifested, despite the use of genetic information. HHS utilizes other examples of genetic diseases to illustrate the same point: A disease is manifested if the diagnosis is based on a physical examination, even if genetic tests are used to confirm the diagnosis. A disease is not manifested if it was diagnosed principally on the basis of genetic information.

HHS utilizes other examples of genetic diseases to illustrate the same point: A disease is manifested if the diagnosis is based on a physical examination, even if genetic tests are used to confirm the diagnosis. A disease is not manifested if it was diagnosed principally on the basis of genetic information.

Overview Summary

Health plans—health insurers, including employer-sponsored group health plans that provide or pay for the cost of medical care, with the exception of long-term care insurance plans—may not use genetic information to determine eligibility, to set the cost of premiums, or to exclude a preexisting condition. A health plan may, however, use genetic information in determining the medical appropriateness of the treatment for which a policyholder is seeking benefits.

Genetic information consists of an individual's family medical history; information about genetic tests; genetic counseling; and genetic education requested or received by an individual, any of the individual's relatives (by blood or by marriage) and any other person eligible for coverage under the individual's group health plan.

Health plans may not use information about a disease or disorder that has been diagnosed principally on the basis of genetic information. Health plans may, however, use information about a disease or disorder that was diagnosed on the basis of a physical examination, even if the diagnosis was confirmed by genetic tests. Similarly, an analysis of proteins or metabolites that is directly related to a disease or disorder that was diagnosed on the basis of a physical examination is not a genetic test.

If you have any questions about this Alert or would like further information, please contact Harry R. Silver, Lisa W. Clark, any other member of the Health Law Practice Group or the attorney in the firm with whom you are regularly in contact.

This article is for general information and does not include full legal analysis of the matters presented. It should not be construed or relied upon as legal advice or legal opinion on any specific facts or circumstances. The description of the results of any specific case or transaction contained herein does not mean or suggest that similar results can or could be obtained in any other matter. Each legal matter should be considered to be unique and subject to varying results. The invitation to contact the authors or attorneys in our firm is not a solicitation to provide professional services and should not be construed as a statement as to any availability to perform legal services in any jurisdiction in which such attorney is not permitted to practice.

Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. The Duane Morris Institute provides training workshops for HR professionals, in-house counsel, benefits administrators and senior managers.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions